Medicare launches program for beneficiaries with serious and chronic illnesses
FDA Accepts GSK's BLA for 5-in-1 Meningococcal Vaccine
The company’s investigational ABCWY vaccine candidate will be reviewed by the FDA by February 14, 2025.
Episode 8: Stay in Sync with Innovations in Medication Decision Support
Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.
FDA: Fasenra Approved As Add-On Maintenance Therapy for Severe Pediatric Asthma
Fasenra was initially approved in 2017 as an add on maintenance therapy in patients aged 12 years and older.
FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications
The antibiotic was approved to treat Staphylococcus aureas bacteremia, acute bacterial skin and skin structure infections, and community-acquired bacterial pneumonia.
FDA Approves Iloperidone for Acute Treatment of Manic, Mixed Episodes in Bipolar I
The drug was previously approved in 2009 to treat schizophrenia.
FDA Clears First Digital Therapeutic to Treat Major Depressive Disorder
Rejoyn from Otsuka Pharmaceutical and Click Therapeutics is a 6-week program that helps enhance cognitive control of emotions through brief therapy lessons and training exercises.
